Prime Savings Club

Prime Savings Club is an e-commerce marketplace and consumer products business associated with Innovus Pharmaceuticals and later Aytu BioPharma. It appears to have operated primarily as a direct-to-consumer online marketplace rather than as a drug developer, and was described by Innovus as an added revenue channel with historical annual revenue of about $2.5 million. Public disclosures indicate the PrimeSavingsClub.com assets were acquired by Innovus in 2019, after which the business was referred to as Delta Prime Savings Club and later listed as a subsidiary of Aytu BioPharma following Aytu's acquisition of Innovus. The available evidence suggests it sold consumer products online, including health-related consumer goods, but it does not appear to have a traditional therapeutic pipeline, R&D platform, or clinical development program.